Filing Details
- Accession Number:
- 0001439222-19-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-15 16:05:09
- Reporting Period:
- 2019-11-13
- Accepted Time:
- 2019-11-15 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439222 | Agios Pharmaceuticals Inc. | AGIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1405288 | A Jacqualyn Fouse | C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-13 | 40,322 | $31.00 | 41,722 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- All shares were purchased at $31.00 per share in an underwritten public offering that closed on November 13, 2019.
Billionaire Hedge Funds
